Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

August 9, 2022

Study Completion Date

September 1, 2022

Conditions
DizzinessVertigoVestibular MigraineVestibular NeuritisLabyrinthitis
Interventions
DEVICE

Otoband

Participants with Dizziness and Vertigo will wear the Otoband set at normal power (effective) during vestibular test battery and outcome measurements will be recorded by the investigator during site visit.

DEVICE

Placebo Device

Participants with Dizziness and Vertigo will wear the placebo device set at low power during vestibular test battery and outcome measurements will be recorded by the investigator during site visit.

Trial Locations (1)

90048

Dizzy and Vertigo Institute of Los Angeles, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Dizzy and Vertigo Institute of Los Angeles

UNKNOWN

lead

Otolith Labs

INDUSTRY

NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness | Biotech Hunter | Biotech Hunter